This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights: EnPro, Harsco, Encore, Timken and Zebra
by Zacks Equity Research
The Zacks Analyst Blog Highlights: EnPro, Harsco, Encore, Timken and Zebra
Middleby's Crown Food Buyout to Boost Steam Cooking Business
by Zacks Equity Research
Middleby's (MIDD) Crown Food buyout to expand its steam cooking equipment offerings in the commercial foodservice industry.
ISM Manufacturing Index Rebounds in November: 5 Picks
by Swarup Gupta
The resurgence in manufacturing was primarily fueled by a spurt in new orders.
Here's Why You Should Hold on to Illinois Tool Stock Now
by Zacks Equity Research
Illinois Tool (ITW) to gain from high demand in North America, margin expansion, lower taxes, and share buybacks despite high costs of sales and forex.
Zacks.com featured highlights include: EnPro, Domtar, Unum, Popular and Wintrust
by Zacks Equity Research
Zacks.com featured highlights include: EnPro, Domtar, Unum, Popular and Wintrust
5 Bargain Stocks Boasting Amazingly Low EV/EBITDA Ratios
by Anindya Barman
We have screened bargain stocks based on EV/EBITDA ratio that offers a clearer picture of a company's valuation and earnings potential.
Here's Why It's Worth Investing in DXP Enterprises (DXPE) Now
by Zacks Equity Research
DXP Enterprises (DXPE) to gain from solid product portfolio, diversified end-market operations, synergistic gains from acquired assets and efforts to improve operational execution.
NPO vs. B: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
NPO vs. B: Which Stock Is the Better Value Option?
Here's Why It's Worth Investing in Graco (GGG) Stock Now
by Zacks Equity Research
Graco (GGG) to gain from strengthening segmental businesses, acquired assets, innovation of products and investment to expand distribution capacity.
Colfax to Enter Medical Solutions Market With DJO Global Deal
by Zacks Equity Research
Colfax's (CFX) entry into the medical solutions industry, with the DJO Global buyout, will boost its earnings in the near term and strengthen its growth opportunities in the long run.
The Zacks Analyst Blog Highlights: Atkore International Group, EnPro Industries, DXP Enterprises, Harsco and Ennis
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Atkore International Group, EnPro Industries, DXP Enterprises, Harsco and Ennis
Here's Why You Must Hold on to Berry Global (BERY) Stock Now
by Zacks Equity Research
Berry Global (BERY) gains from solid business opportunities in its segments, investments and buyouts. However, increase in costs, high debts and forex woes are creating headwinds for the company.
Manufacturing Output Rises for Fifth Straight Month: 5 Picks
by Swarup Gupta
Manufacturers have turned to strategies such as nearshoring and reshoring to battle new challenges.
Berry Global (BERY) Beats Q4 Earnings & Revenue Estimates
by Zacks Equity Research
Berry Global's (BERY) fourth-quarter fiscal 2018 results gain from organic sales and buyouts, partially offset by higher costs of goods sold. Earnings surpass the Zacks Consensus Estimate by 2.3%.
IDEX Gains From Solid Demand & Buyouts Amid Cost & Forex Woes
by Zacks Equity Research
IDEX (IEX) gains from strengthening end markets, efforts to improve productivity, geographical expansion and buyouts. However, high costs and forex woes are headwinds.
Roper's (ROP) Board Okays 12% Hike in Quarterly Dividend Rate
by Zacks Equity Research
Roper (ROP) rewards shareholders with 12% hike in the quarterly dividend rate. This underpins the company's strong cash position.
The Zacks Analyst Blog Highlights: DXP Enterprises, Bristol-Myers Squibb, EnPro Industries, Illumina and NetApp
by Zacks Equity Research
The Zacks Analyst Blog Highlights: DXP Enterprises, Bristol-Myers Squibb, EnPro Industries, Illumina and NetApp
Wall Street Likely to Sustain Post-Midterm Rally: 5 Picks
by Nalak Das
Investors' optimism has been revived on risky assets like equities with a divided U.S. Congress.
NPO or IEX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NPO vs. IEX: Which Stock Is the Better Value Option?
EnPro Industries (NPO) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
EnPro (NPO) delivered earnings and revenue surprises of 23.64% and 3.03%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
EnPro Industries (NPO) Q3 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
EnPro (NPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EnPro Industries (NPO) Misses Q2 Earnings Estimates
by Zacks Equity Research
EnPro (NPO) delivered earnings and revenue surprises of -33.04% and 6.97%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Is Parker-Hannifin (PH) Likely to Disappoint in Q4 Earnings?
by Zacks Equity Research
Sluggishness in key natural resources markets, inflation in prices for core materials and high costs are likely to hurt Parker-Hannifin's (PH) financials in fourth-quarter fiscal 2018.
Industrial Stock Earnings Slated for Aug 1: CMPR, BDC & More
by Zacks Equity Research
Strengthening global economy and expanding manufacturing sector in the U.S. should be conducive to growth for industrial companies.
Welbilt (WBT) Signs Deal With Xiaomi & Youle, Shares Move Up
by Zacks Equity Research
Welbilt's (WBT) deal with Xiaomi will enable it to provide its innovative ovens and artificial intelligent solutions through the latter's stores across China.